XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:          
Net income $ 73,931 $ 65,289 $ 127,981 $ 98,212  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization 47,715 45,994 94,538 91,900  
Gain on sale of real estate (449) 0 (18,215) 0  
Other non-cash expenses, net     4,230 4,166  
Changes in operating assets and liabilities:          
Increase in due from third party managers, net     (27,020) (24,187)  
Increase in other assets, net     (1,137) (8,044)  
Increase in accounts payable and other liabilities     1,578 8,517  
Net cash provided by operating activities     181,955 170,564  
Cash flows from investing activities:          
Acquisition of hotel properties, net     (197,285) (30,948)  
Disbursements for potential acquisitions, net     0 (1,070)  
Capital improvements     (44,997) (35,085)  
Net proceeds from sale of real estate     40,056    
Net cash used in investing activities     (202,226) (67,103)  
Cash flows from financing activities:          
Repurchases of common shares     (15,476) (6,831)  
Common shares surrendered to satisfy employee withholding requirements     (5,050) (5,742)  
Distributions paid to common shareholders (58,000) (54,900) (128,201) (128,282)  
Equity issuance costs     (332) (50)  
Proceeds from revolving credit facility     322,900 166,500  
Payments on revolving credit facility     (153,900) (142,500)  
Proceeds from term loans and senior notes     0 50,000  
Payments of mortgage debt and other loans     (4,547) (41,757)  
Principal payments on finance leases     (222) (136)  
Net cash provided by (used in) financing activities     15,172 (108,798)  
Net change in cash, cash equivalents and restricted cash     (5,099) (5,337)  
Cash, cash equivalents and restricted cash, beginning of period     43,618 43,512 $ 43,512
Cash, cash equivalents and restricted cash, end of period 38,519 38,175 38,519 38,175 43,618
Supplemental cash flow information:          
Interest paid     36,083 32,703  
Income taxes paid     745 987  
Supplemental disclosure of noncash investing and financing activities:          
Accrued distribution to common shareholders 19,270 18,279 19,270 18,279 31,400
Accrued capital expenditures     3,404 3,803  
Reconciliation of cash, cash equivalents and restricted cash:          
Cash and cash equivalents, beginning of period     10,287 4,077 4,077
Restricted cash-furniture, fixtures and other escrows, beginning of period     33,331 39,435 39,435
Cash, cash equivalents and restricted cash, beginning of period     43,618 43,512 43,512
Cash and cash equivalents, end of period 7,224 6,420 7,224 6,420 10,287
Restricted cash-furniture, fixtures and other escrows, end of period 31,295 31,755 31,295 31,755 33,331
Cash, cash equivalents and restricted cash, end of period $ 38,519 $ 38,175 $ 38,519 $ 38,175 $ 43,618